サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605712

ジンクフィンガーヌクレアーゼ技術の世界市場：技術プラットフォーム別・送達方法別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Zinc Finger Nuclease Technology Market, By Technology Platform, By Delivery Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 356 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
ジンクフィンガーヌクレアーゼ技術の世界市場：技術プラットフォーム別・送達方法別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月01日
発行: AnalystView Market Insights
ページ情報: 英文 356 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ジンクフィンガーヌクレアーゼ技術の市場規模は、2023年に7億4,400万米ドルと評価され、2024年から2032年にかけて21.5%のCAGRで拡大

ジンクフィンガーヌクレアーゼ技術の市場力学

遺伝子編集イニシアティブに対する政府の支援がジンクフィンガーヌクレアーゼ技術市場の成長を促進

政府の取り組みがジンクフィンガーナクレアーゼ (ZFN) 技術市場の成長を大きく後押ししています。例えば、米国国立衛生研究所 (NIH) は、精密医療や農業への応用のためにZFN技術を使用するものを含む遺伝子編集プロジェクトに多額の資金を割り当てています。2021年、NIHは遺伝子編集研究に1億9,000万米ドルを投資し、治療用遺伝子編集の技術革新を促進しました。さらに、欧州連合のHorizon 2020プログラムは、ZFNを用いたさまざまな臨床試験を支援しています。世界各国の政府がZFNを含む遺伝子編集技術の変革の可能性を認めているため、投資の増加と有利な政策が医療から農業まで幅広い産業での採用を促進しています。また、FDAやEMAといった機関が遺伝子編集療法に関するガイドラインの明確化に取り組むなど、規制環境も改善されており、ZFN市場の拡大に資する環境が整いつつあります。さらに、バイオテクノロジー企業、研究機関、政府機関の協力により、遺伝病や遺伝子組み換え作物へのZFNの応用が強化され続けています。

ジンクフィンガーヌクレアーゼ技術市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2024-2032年) に約21.5%のCAGRで毎年成長すると予測されています。

技術プラットフォームのセグメンテーションに基づくと、モジュラーアセンブリは2023年に最大の市場シェアを示すと予測されました。

送達方法のセグメンテーションに基づくと、2023年にはIn Vivoが主要タイプでした。

地域別では、北米が2023年に主要な収益源となった。

ジンクフィンガーヌクレアーゼ技術市場：セグメンテーション分析

ジンクフィンガーヌクレアーゼ技術の世界市場は、技術プラットフォーム、送達方法、エンドユーザー、地域に基づいてセグメント化されます。

市場は技術プラットフォームに基づいて2つのカテゴリーに分けられる：モジュラーアセンブリーとOPEN (オリゴマー化プールエンジニアリング) です。Modular Assembly技術プラットフォームは、遺伝子編集ツールの設計における柔軟性と効率性により、ジンクフィンガーヌクレアーゼ技術市場をリードすると予想されます。OPEN (Oligomerized Pool Engineering) がこれに続き、特定の用途に的を絞った精密な遺伝子編集機能を提供します。

市場は送達方法によって2つのカテゴリーに分けられる：生体内と生体外です。生体内送達法は、ジンクフィンガーヌクレアーゼ技術市場をリードすると予想されます。これは、生体内に直接適用できるため、より効率的な遺伝子編集が可能になるためです。生体外がこれに続き、再導入前に生体外の細胞で標的を絞った編集を行う。

ジンクフィンガーヌクレアーゼ技術市場：地域別分析

北米はジンクフィンガー・ヌクレアーゼ (ZFN) 技術市場の主要地域であり、その主な理由は政府による多大な支援、高度な医療インフラ、堅調なバイオテクノロジー産業の成長です。2022年、米国政府は遺伝子編集イニシアチブに5億米ドル以上の資金を割り当て、希少疾患の遺伝子治療などさまざまな医療用途でのZFN技術の採用に貢献しています。またこの地域には、サンガモ・セラピューティクス社のような大手バイオテクノロジー企業もあり、同社は現在進行中の臨床試験やカリフォルニア大学などの機関との提携を通じて、ZFNを用いた遺伝子編集による遺伝性疾患の治療を積極的に進めています。さらに、遺伝子編集製品の承認プロセスを合理化する米国FDAの取り組みが、ZFN技術の採用に有利な規制環境を作り出しています。欧州は、英国やドイツのような国々が遺伝子編集研究にますます力を入れており、主要機関とバイオテクノロジー企業との共同研究によって証明されています。さらに、アジア太平洋は、中国やインドのような国々における研究投資の増加とバイオテクノロジー・エコシステムの成長により、有望な市場として浮上しています。

ジンクフィンガーヌクレアーゼ技術市場：競合情勢

ジンクフィンガー・ヌクレアーゼ (ZFN) 技術市場の競合情勢は、Sangamo Therapeutics社やPrecision Biosciences社などの主要企業を筆頭に、北米企業が大部分を占めています。米国に本社を置くSangamo Therapeutics社は、血友病の遺伝子治療を進めるためのファイザー社との提携など、遺伝子疾患に対するZFNベースの治療法を開発する継続的な取り組みで評価されています。2022年、サンガモ社は自己免疫疾患に対するZFNベースの治療を開発するためにサノフィ社と戦略的パートナーシップを締結したが、これはZFN技術に対する信頼の高まりを反映したものです。もう一つの注目すべきプレーヤーであるプレシジョン・バイオサイエンシズ社は、鎌状赤血球症など様々な遺伝性疾患に対処するためにZFN技術を用いた臨床試験で躍進しています。欧州では、ZFNの応用を改良するためのバイオテクノロジー企業と学術機関との共同研究などが注目されます。一方、アジア太平洋地域では、中国のバイオテクノロジー・エコシステムの台頭が市場ダイナミクスの変化に寄与しており、現地企業は政府支援の研究イニシアティブに支えられながら、ZFNを含む遺伝子編集技術への注力を強めています。

目次

第1章 ジンクフィンガーヌクレアーゼ技術市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ジンクフィンガーヌクレアーゼ技術の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ジンクフィンガーヌクレアーゼ技術市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 ジンクフィンガーヌクレアーゼ技術市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 ジンクフィンガーヌクレアーゼ技術の市場情勢

  • ジンクフィンガーヌクレアーゼ技術の市場シェア分析 (2023年)
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ジンクフィンガーヌクレアーゼ技術市場：技術プラットフォーム別

  • 概要
    • セグメントシェア分析：技術プラットフォーム別
    • モジュラーアセンブリ
    • OPEN (オリゴマー化プールエンジニアリング)

第8章 ジンクフィンガーヌクレアーゼ技術市場：送達方法別

  • 概要
    • セグメントシェア分析：送達方法別
    • 生体内
    • 生体外

第9章 ジンクフィンガーヌクレアーゼ技術市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 学術研究機関
    • CRO

第10章 ジンクフィンガーヌクレアーゼ技術市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：ジンクフィンガーヌクレアーゼ技術業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Agenus Inc.
    • Amgen Inc.
    • Beam Therapeutics Inc.
    • Bluebird Bio, Inc.
    • CRISPR Therapeutics AG
    • Editas Medicine, Inc.
    • GenScript Biotech Corporation
    • Horizon Discovery Group plc
    • Intellia Therapeutics, Inc.
    • Lonza Group AG
    • Novartis AG
    • Poseida Therapeutics, Inc.
    • Precision BioSciences, Inc.
    • Sangamo Therapeutics, Inc.
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific Inc.
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4337

REPORT HIGHLIGHT

The Zinc Finger Nuclease Technology Market size was valued at USD 744 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Zinc Finger Nuclease (ZFN) technology market focuses on the development and application of highly specific gene-editing tools used for targeted DNA modification. ZFNs are used in a variety of research and therapeutic applications, including gene therapy, crop development, and disease modeling. As the potential of gene editing becomes increasingly recognized, the demand for precise, reliable, and efficient gene-editing tools has grown. According to a report from the National Institutes of Health, ZFN technology is being explored for its potential to correct genetic defects, especially in rare genetic disorders. The market benefits from advancements in biotechnology, as ZFNs offer a high degree of specificity, reducing off-target effects compared to other gene-editing technologies like CRISPR. However, high development costs and regulatory hurdles related to the use of ZFNs in human therapy pose challenges. Despite this, ongoing research, collaborations between biotech firms, and government support for gene-editing initiatives are opening up substantial market opportunities in healthcare, agriculture, and environmental sustainability.

Zinc Finger Nuclease Technology Market- Market Dynamics

Government Support for Gene-Editing Initiatives Drives Growth in the Zinc Finger Nuclease Technology Market

Government initiatives are significantly boosting the growth of the Zinc Finger Nuclease (ZFN) technology market. For instance, the U.S. National Institutes of Health (NIH) has allocated substantial funding for gene-editing projects, including those using ZFN technology for precision medicine and agricultural applications. In 2021, the NIH invested $190 million in gene-editing research, fostering innovation in therapeutic gene editing. Additionally, the European Union's Horizon 2020 program has supported various ZFN-based clinical trials. As governments globally acknowledge the transformative potential of gene-editing technologies, including ZFN, increased investments and favorable policies are driving adoption in industries ranging from healthcare to agriculture. The regulatory environment has also improved, with agencies such as the FDA and EMA working on clearer guidelines for gene-editing therapies, creating a conducive environment for ZFN market expansion. Furthermore, collaborations between biotech firms, research institutes, and governmental bodies continue to enhance the application of ZFN in genetic diseases and genetically modified crops.

Zinc Finger Nuclease Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Technology Platform segmentation, Modular Assembly was predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, In Vivo was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Zinc Finger Nuclease Technology Market- Segmentation Analysis:

The Global Zinc Finger Nuclease Technology Market is segmented on the basis of Technology Platform, Delivery Method, End-User, and Region.

The market is divided into two categories based on Technology Platform: Modular Assembly and OPEN (Oligomerized Pool Engineering). The Modular Assembly technology platform is expected to lead the Zinc Finger Nuclease Technology market due to its flexibility and efficiency in designing gene-editing tools. OPEN (Oligomerized Pool Engineering) follows, offering targeted and precise gene-editing capabilities for specific applications.

The market is divided into two categories based on the Delivery Method: In Vivo and Ex Vivo. In Vivo delivery method is anticipated to lead the Zinc Finger Nuclease Technology market, owing to its direct application in living organisms, allowing for more efficient gene editing. Ex Vivo follows, offering targeted editing in cells outside the organism before reintroduction.

Zinc Finger Nuclease Technology Market- Geographical Insights

North America is the leading region in the Zinc Finger Nuclease (ZFN) technology market, primarily due to significant government support, advanced healthcare infrastructure, and robust biotech industry growth. In 2022, the U.S. government allocated over $500 million in funding for gene-editing initiatives, contributing to the adoption of ZFN technology in various medical applications, such as gene therapies for rare diseases. The region also boasts major biotech companies like Sangamo Therapeutics, which is actively advancing ZFN-based gene-editing treatments for genetic disorders, with ongoing clinical trials and collaborations with institutions like the University of California. Additionally, the U.S. FDA's initiatives to streamline approval processes for gene-editing products have created a favorable regulatory environment for ZFN technology adoption. Europe follows closely with countries like the UK and Germany, which are increasingly focusing on gene-editing research, evidenced by collaborations between leading institutions and biotech companies. Furthermore, Asia-Pacific is emerging as a promising market due to increased research investments and a growing biotech ecosystem in countries like China and India.

Zinc Finger Nuclease Technology Market- Competitive Landscape:

The competitive landscape of the Zinc Finger Nuclease (ZFN) technology market is largely dominated by North American companies, with key players like Sangamo Therapeutics and Precision Biosciences leading the charge. Sangamo Therapeutics, headquartered in the U.S., is recognized for its ongoing efforts to develop ZFN-based therapies for genetic disorders, including its collaboration with Pfizer to advance gene therapies for hemophilia. In 2022, Sangamo entered into a strategic partnership with Sanofi to develop ZFN-based treatments for autoimmune diseases, reflecting the growing confidence in ZFN technology. Another notable player, Precision Biosciences, has made strides in clinical trials using ZFN technology to address various genetic conditions, such as sickle cell disease. In Europe, notable developments include collaborations between biotech firms and academic institutions to refine ZFN applications. Meanwhile, in the Asia-Pacific region, China's rising biotech ecosystem is contributing to a shift in the market dynamics, with local companies increasing their focus on gene-editing technologies, including ZFNs, supported by government-backed research initiatives.

Recent Developments:

In May 2024, Researchers from Hiroshima University and the Japanese National Institute of Advanced Industrial Science enhanced Zinc Finger Nuclease (ZFN) technology using machine learning-driven modular assembly systems. This advancement improves gene editing efficiency, offering a promising tool for treating genetic disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Agenus Inc.
  • Amgen Inc.
  • Beam Therapeutics Inc.
  • Bluebird Bio, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Intellia Therapeutics, Inc.
  • Lonza Group AG
  • Novartis AG
  • Poseida Therapeutics, Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY TECHNOLOGY PLATFORM- MARKET ANALYSIS, 2019 - 2032

  • Modular Assembly
  • OPEN (Oligomerized Pool Engineering)

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • In Vivo
  • Ex Vivo

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CROs

GLOBAL ZINC FINGER NUCLEASE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Zinc Finger Nuclease Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Zinc Finger Nuclease Technology Market Snippet by Technology Platform
    • 2.1.2. Zinc Finger Nuclease Technology Market Snippet by Delivery Method
    • 2.1.3. Zinc Finger Nuclease Technology Market Snippet by End-User
    • 2.1.4. Zinc Finger Nuclease Technology Market Snippet by Country
    • 2.1.5. Zinc Finger Nuclease Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Zinc Finger Nuclease Technology Key Market Trends

  • 3.1. Zinc Finger Nuclease Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Zinc Finger Nuclease Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Zinc Finger Nuclease Technology Market Opportunities
  • 3.4. Zinc Finger Nuclease Technology Market Future Trends

4. Zinc Finger Nuclease Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Zinc Finger Nuclease Technology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Zinc Finger Nuclease Technology Market Landscape

  • 6.1. Zinc Finger Nuclease Technology Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Zinc Finger Nuclease Technology Market - By Technology Platform

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Platform, 2023 & 2032 (%)
    • 7.1.2. Modular Assembly
    • 7.1.3. OPEN (Oligomerized Pool Engineering)

8. Zinc Finger Nuclease Technology Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. In Vivo
    • 8.1.3. Ex Vivo

9. Zinc Finger Nuclease Technology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Academic Research Institutes
    • 9.1.4. CROs

10. Zinc Finger Nuclease Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Zinc Finger Nuclease Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Zinc Finger Nuclease Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Zinc Finger Nuclease Technology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Zinc Finger Nuclease Technology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Zinc Finger Nuclease Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Platform, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Zinc Finger Nuclease Technology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Agenus Inc.
    • 11.2.2. Amgen Inc.
    • 11.2.3. Beam Therapeutics Inc.
    • 11.2.4. Bluebird Bio, Inc.
    • 11.2.5. CRISPR Therapeutics AG
    • 11.2.6. Editas Medicine, Inc.
    • 11.2.7. GenScript Biotech Corporation
    • 11.2.8. Horizon Discovery Group plc
    • 11.2.9. Intellia Therapeutics, Inc.
    • 11.2.10. Lonza Group AG
    • 11.2.11. Novartis AG
    • 11.2.12. Poseida Therapeutics, Inc.
    • 11.2.13. Precision BioSciences, Inc.
    • 11.2.14. Sangamo Therapeutics, Inc.
    • 11.2.15. Sigma-Aldrich Corporation
    • 11.2.16. Thermo Fisher Scientific Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us